New York State Common Retirement Fund Purchases 18,443 Shares of Trupanion, Inc. (NASDAQ:TRUP)

New York State Common Retirement Fund lifted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 28.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 83,634 shares of the financial services provider's stock after buying an additional 18,443 shares during the quarter. New York State Common Retirement Fund owned approximately 0.20% of Trupanion worth $3,117,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in TRUP. Vanguard Group Inc. lifted its holdings in Trupanion by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock worth $173,362,000 after purchasing an additional 45,653 shares during the period. Marshall Wace LLP grew its stake in Trupanion by 6.9% during the 4th quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider's stock valued at $43,459,000 after acquiring an additional 57,804 shares in the last quarter. Balyasny Asset Management L.P. grew its stake in Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after acquiring an additional 661,559 shares in the last quarter. Northern Trust Corp grew its stake in Trupanion by 9.0% during the 4th quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock valued at $17,749,000 after acquiring an additional 30,549 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its stake in shares of Trupanion by 170.7% in the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock valued at $16,248,000 after buying an additional 212,545 shares in the last quarter.

Trupanion Price Performance

Shares of TRUP stock traded up $0.79 during trading hours on Friday, hitting $49.81. 300,702 shares of the company's stock were exchanged, compared to its average volume of 570,788. The stock's 50-day moving average is $50.70 and its 200-day moving average is $43.88. The stock has a market cap of $2.13 billion, a price-to-earnings ratio of -498.05 and a beta of 1.82. Trupanion, Inc. has a 52 week low of $29.70 and a 52 week high of $57.90. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.70 and a quick ratio of 1.70.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02. The firm had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative return on equity of 1.33% and a negative net margin of 0.32%. The company's quarterly revenue was up 11.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.16) earnings per share. As a group, research analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Insider Activity at Trupanion

In related news, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total value of $183,440.00. Following the sale, the chief executive officer owned 118,784 shares of the company's stock, valued at approximately $5,447,434.24. This trade represents a 3.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO John R. Gallagher sold 4,000 shares of the business's stock in a transaction that occurred on Thursday, May 29th. The stock was sold at an average price of $47.90, for a total value of $191,600.00. Following the transaction, the chief operating officer directly owned 26,966 shares in the company, valued at $1,291,671.40. This trade represents a 12.92% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 11,562 shares of company stock valued at $544,870. 5.42% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on TRUP shares. Lake Street Capital decreased their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Piper Sandler upped their target price on Trupanion from $52.00 to $62.00 and gave the company an "overweight" rating in a research note on Thursday, July 3rd. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Trupanion currently has an average rating of "Moderate Buy" and a consensus target price of $53.80.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.